MedDataX Logo

LACE+ and MRS Score Readmission Rate Assessment

NCT ID: NCT04365673

Last Updated: 2022-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-07

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of a Medication Review on Hospital Readmission: (ConcReHosp)

NCT02734017

Re-hospitalization
TERMINATED NA

Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence

NCT02031406

Medication Adherence & Literacy to Predict Readmission Post-discharge Pharmacist Counseling to Prevent Readmissions
TERMINATED NA

Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

NCT05017948

Iatrogenic Disease Risk Reduction
COMPLETED NA

Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program

NCT05751980

Communication Research
COMPLETED NA

Hospice Quality Score Assessment Post Pharmacist Intervention

NCT04361669

Respiratory Disease Cardiovascular Diseases Neurologic Disorder +2 more
WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is evaluate a program that provides transition of care services to a local Tucson hospital involving activities designed to reduce 30 day post hospital discharge readmission rates. The organization has had a fee for service contract with this hospital since 2017 to provide pharmacist delivered transition of care services. The organization collects internal tracking outcome data as part of the contract deliverable and is required to report it to the hospital once per month. The investigators look to assess LACE+ and medication risk scores to learn if there is an association with the 30 day post hospital discharge readmission rate post pharmacist intervention. The outcomes will not be generalizable and will be reported back to the hospital client to demonstrate value added.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospitalism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Readmitted

Patients that were readmitted within 30 days post hospital discharge

Pharmacist transition of care consultation

Intervention Type OTHER

Pharmacist-delivered comprehensive medication review

Not readmitted

Patients that were not readmitted within 30 days post hospital discharge

Pharmacist transition of care consultation

Intervention Type OTHER

Pharmacist-delivered comprehensive medication review

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharmacist transition of care consultation

Pharmacist-delivered comprehensive medication review

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those referred to receive transition of care services between January 2018 to December 2019 and were discharged on 10 or more medications.

Exclusion Criteria

* 89 years or older
Minimum Eligible Age

18 Years

Maximum Eligible Age

88 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tabula Rasa HealthCare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer Bingham, PharmD

Role: PRINCIPAL_INVESTIGATOR

Tabula Rasa HealthCare

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tabula Rasa HealthCare

Tucson, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRHC_RD_LACEMRS_2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges
NCT07018232 COMPLETED
Using Barcode Technology to Improve Medication Safety
NCT00243373 COMPLETED NA
Discharge in the AM
NCT05370638 COMPLETED NA
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
NCT04071951 ACTIVE_NOT_RECRUITING NA
Electronic Medication Adherence Reporting and Feedback During Care Transitions
NCT03475030 COMPLETED NA
Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization
NCT02805270 COMPLETED NA
Outcomes Study of MTM in a Medicare ACO
NCT02875925 COMPLETED NA
A Randomised Pilot Study of the REVISiT Intervention
NCT04586595 COMPLETED NA
Pharmaceutical Consultation at Hospital Discharge and Adherence to Anti-infective Treatment
NCT02126930 COMPLETED NA
Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)
NCT01065675 TERMINATED NA
Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care
NCT03666793 COMPLETED NA
Collaborative Home Visits to Reduce Hospital Readmissions and Improve Medication Use During Transitions of Care
NCT02087072 WITHDRAWN
Standardized Patient-Centered Medication Review in Home Hospice
NCT03972163 COMPLETED NA
Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge
NCT05062655 UNKNOWN NA
Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication
NCT01684176 COMPLETED NA
Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting
NCT03181906 COMPLETED NA
Evaluation of PatientToc in Community Pharmacies
NCT05235620 ENROLLING_BY_INVITATION
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
NCT02752997 COMPLETED NA
Comparison of MedBook Portal and Usual Care in Medication Reconciliation at Primary Healthcare Upon Hospital Discharge
NCT06517160 COMPLETED NA
Over-the-counter (OTC) Labels for Older Adults
NCT04345731 COMPLETED NA
Pharmacist Discharge Medication Reconciliation Study
NCT01226589 COMPLETED NA
Medicines Reconciliation at an Intensive Care Unit
NCT03173690 UNKNOWN NA
Medication Reconciliation Process in Clinical Practice
NCT07001137 COMPLETED
SCORE of Medication Error in Internal Medecin Unit
NCT03422484 COMPLETED
Medication Reconciliation at Discharge: Impact on Patient's Care
NCT03029052 COMPLETED NA